Polaris Venture Management Co. V as of March 31, 2017
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 9 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Selecta Biosciences (RNAC) | 29.5 | $28M | 1.9M | 14.32 | |
| Pulmatrix | 13.5 | $13M | 3.6M | 3.49 | |
| Genocea Biosciences | 12.8 | $12M | 2.0M | 6.09 | |
| Fate Therapeutics (FATE) | 12.1 | $11M | 2.5M | 4.55 | |
| T2 Biosystems | 10.6 | $9.9M | 1.9M | 5.26 | |
| Trevena | 8.1 | $7.5M | 2.1M | 3.67 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 6.8 | $6.4M | 1.8M | 3.50 | |
| Ocular Therapeutix (OCUL) | 3.8 | $3.6M | 383k | 9.28 | |
| Cerulean Pharma | 2.9 | $2.7M | 3.3M | 0.81 |
